Sponsor or institution
Clinical trials and research at Mark Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $1.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Gene therapy for aging-related Parkinson’s disease (idPD) tested in animals and moved toward humans
A patient-facing overview of a gene therapy approach aiming to slow or modify idiopathic Parkinson’s disease by delivering a therapeutic gene in the brain, with plans to test safety and efficacy in advanced animal models before human studies.
-
One-time gene therapy for Parkinson's without known genetic causes
A one-time gene treatment using a harmless virus to try to stop disease progression in people with idiopathic Parkinson's disease (no known genetic cause).
-
Gene therapy aimed at treating idiopathic Parkinson's Disease
This study is testing a new gene therapy for people with idiopathic Parkinson's Disease, which is a common form of the condition that doesn't run in families, to see if it can help improve brain function and slow down symptoms.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.